HE4

287 Can HE4 replace CA 125 as a biomarker in ovarian cancer?
A Ranjan, H Dubey, P Tanwar

International Journal of Gynecologic Cancer Oct 2021, 31 (Suppl 3) A222-A223; DOI: 10.1136/ijgc-2021-ESGO.378
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Francesco Plotti, Giuseppe Scaletta, Stella Capriglione, Roberto Montera, Daniela Luvero, Salvatore Lopez, Alessandra Gatti, Carlo De Cicco Nardone, Corrado Terranova, Roberto Angioli

International Journal of Gynecologic Cancer May 2017, 27 (4) 696-702; DOI: 10.1097/IGC.0000000000000944
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers
György Sölétormos, Michael J. Duffy, Suher Othman Abu Hassan, René H.M. Verheijen, Bengt Tholander, Robert C. Bast, Katja N. Gaarenstroom, Catharine M. Sturgeon, Johannes M. Bonfrer, Per Hyltoft Petersen, Hugo Troonen, Gian CarloTorre, Jan Kanty Kulpa, Malgorzata K. Tuxen, Raphael Molina

International Journal of Gynecologic Cancer Jan 2016, 26 (1) 43-51; DOI: 10.1097/IGC.0000000000000586
Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy
Ignacio Zapardiel, Mikel Gorostidi, Antonella Ravaggi, Maria T. Allende, Margarida Silveira, Daniel Abehsera, Ronalds Macuks

International Journal of Gynecologic Cancer Jan 2016, 26 (1) 52-55; DOI: 10.1097/IGC.0000000000000579
Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis
Farshid Dayyani, Steffen Uhlig, Bertrand Colson, Kirsten Simon, Vinzent Rolny, David Morgenstern, Matthew Schlumbrecht

International Journal of Gynecologic Cancer Nov 2016, 26 (9) 1586-1593; DOI: 10.1097/IGC.0000000000000804
Accuracy of Serum Human Epididymis Protein 4 in Ovarian Cancer Diagnosis: A Systematic Review and Meta-Analysis
Ana Cristina Lacerda Macedo, Maria Inês da Rosa, Suéli Lumertz, Lidia Rosi Medeiros

International Journal of Gynecologic Cancer Sep 2014, 24 (7) 1222-1231; DOI: 10.1097/IGC.0000000000000192
Serum HE4 as a Useful Biomarker in Discriminating Ovarian Cancer From Benign Pelvic Disease
Hong Zheng, Yunong Gao

International Journal of Gynecologic Cancer Jul 2012, 22 (6) 1000-1005; DOI: 10.1097/IGC.0b013e318249bee7
Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer
Johanna Hynninen, Annika Auranen, Kirsti Dean, Maija Lavonius, Olli Carpen, Antti Perheentupa, Marko Seppänen, Seija Grénman

International Journal of Gynecologic Cancer Nov 2011, 21 (9) 1573-1578; DOI: 10.1097/IGC.0b013e3182225509
Diagnostic Value of Serum Human Epididymis Protein 4 (HE4) in Ovarian Carcinoma: A Systematic Review and Meta-Analysis
Li Wu, Zhi-Yuan Dai, Yong-Hong Qian, Yan Shi, Feng-Ju Liu, Chen Yang

International Journal of Gynecologic Cancer Sep 2012, 22 (7) 1106-1112; DOI: 10.1097/IGC.0b013e318263efa2
Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study
Francesco Fanfani, Stefano Restaino, Stefania Cicogna, Marco Petrillo, Marcella Montico, Emanuele Perrone, Oriano Radillo, Rossella De Leo, Matteo Ceccarello, Giovanni Scambia, Giuseppe Ricci

International Journal of Gynecologic Cancer Jul 2017, 27 (6) 1200-1205; DOI: 10.1097/IGC.0000000000001015

Main menu

HE4

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

HE4

Pages